ZUCLOPENTHIXOL ACETATE (5-PERCENT IN VISCOLEO) - SINGLE-DOSE TREATMENT FOR ACUTELY DISTURBED PSYCHOTIC-PATIENTS

被引:17
作者
CHAKRAVARTI, SK [1 ]
MUTHU, A [1 ]
MUTHU, PK [1 ]
NAIK, P [1 ]
PINTO, RT [1 ]
机构
[1] LUTON & DUNSTABLE HOSP,LUTON LU4 0DZ,BEDS,ENGLAND
关键词
Major; Psychoses; Tranquillizing Agents; Zuclopenthixol Acetate;
D O I
10.1185/03007999009111492
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Twenty-five acutely disturbed psychotic patients were treated in an open study with a single injection of zuclopenthixol acetate 5% in 'Viscoleo', a thin vegetable oil. Patients were assessed post-injection for 3 days using the BPRS, CGI, and a specially designed behaviour/activity scale. Doses of 50 to ISO mg proved effective in 24 (96%) of 25 patients, with pronounced and rapid reduction in psychotic symptoms over the study period. The mean total BPRS score after 72 hours was reduced by over 57%. Tranquillization and sedation appeared within 15 to 90 minutes of injection. Unwanted symptoms were generally mildandoflow incidence. The results showed that a single injection of zuclopenthixol acetate 5% in 'Viscoleo' provided rapid tranquillization and sedation coupled with an antipsychotic effect over 3 days. This profile offers a distinct advantage over neuroleptic preparations conventionally used for the initial treatment of acutely disturbed psychotic patients. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:58 / 65
页数:8
相关论文
共 13 条
[1]   ZUCLOPENTHIXOL ACETATE IN VISCOLEO - A NEW DRUG FORMULATION - AN OPEN NORDIC MULTICENTER STUDY OF ZUCLOPENTHIXOL ACETATE IN VISCOLEO IN PATIENTS WITH ACUTE PSYCHOSES INCLUDING MANIA AND EXACERBATION OF CHRONIC PSYCHOSES [J].
AMDISEN, A ;
NIELSEN, MS ;
DENCKER, SJ ;
FENSBO, C ;
AHLFORS, UG ;
GRAVEM, A ;
BAASTRUP, PC ;
BJERKENSTEDT, L ;
GUNBY, B ;
WIESEL, FA ;
LINDHOLM, H ;
RAFAELSEN, OJ ;
FREDSLUNDANDERSEN, K ;
THOMSEN, NJ ;
ROSELL, I ;
PAKARINEN, P ;
HARMA, P ;
AMTHOR, KF ;
KASTBERG, S ;
ABELSKOV, J .
ACTA PSYCHIATRICA SCANDINAVICA, 1987, 75 (01) :99-107
[2]  
AMDISEN A, 1986, PSYCHOPHARMACOLOGY, V90, P412
[3]  
BHATTACHARYYA SN, 1987, PHARMATHERAPEUTICA, V5, P1
[4]  
DENCKER SJ, 1980, ACTA PSYCHIATR S279, V61, P10
[5]  
DONLON PT, 1980, ARCH GEN PSYCHIAT, V37, P691
[6]  
GRAVEM A, 1981, Acta Psychiatrica Scandinavica Supplementum, V64, P13, DOI 10.1111/j.1600-0447.1981.tb06208.x
[7]  
Guy W, 1976, ECDEU ASSESSMENT MAN, P218, DOI DOI 10.1016/J.BIOPHA.2016.11.034
[8]  
LINGJAERDE O, 1987, ACTA PSYCHIATR S334, V76, P81
[9]  
MATAR AM, 1987, 3RD PAN AR C PSYCH A
[10]   PROBABLE TOXIC NECROSIS AFTER PROLONGED FLUSPIRILENE ADMINISTRATION [J].
MCCREADIE, RG ;
KIERNAN, WES ;
VENNER, RM ;
DENHOLM, RB .
BRITISH MEDICAL JOURNAL, 1979, 1 (6162) :523-524